Companies: 10,795·Total market cap: $144.5T
Kyto Technology and Life Science, Inc.

Kyto Technology and Life Science, Inc.

KBPHOTCFinancial Services
$1.00
$-0.84(-45.65%)
Market Cap$13287600
P/E Ratio
52W High$1.0
52W Low$1.0

Kyto Technology and Life Science, Inc. (KBPH) Revenue

Annual & quarterly revenue history · segment & region breakdown

KBPH · revenue · updated Jun 9, 2026

Core revenue metrics

Kyto Technology and Life Science, Inc. trailing twelve-month (TTM) revenue is $-0.00B, a decrease of 100.00% year-over-year from $0.00B in FY2021.

TTM revenue
$-0.00B
4-quarter sum · USD
YoY growth
-100.00%
vs FY2021 $0.00B
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$-1K
1 employees
FY2021
$0.00B
FY2020
$0.00B
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Kyto Technology and Life Science, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

20212004 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2021-03-31$0.00B-$0.00B-100.00%
2020-03-31$0.00B+$0.00B+57.22%
2019-03-31$0.00B+$0.00B
2018-03-31$0.00B+$0.00B
2017-03-31$0.00B+$0.00B
2016-03-31$0.00B+$0.00B
2015-03-31$0.00B+$0.00B
2014-03-31$0.00B+$0.00B
2013-03-31$0.00B+$0.00B
2012-03-31$0.00B+$0.00B
KBPH revenue by year · KBPH revenue history · KBPH annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Kyto Technology and Life Science, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Kyto Technology and Life Science, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Kyto Technology and Life Science, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

KBPH revenue · 4 questions

KBPH's trailing twelve-month (TTM) revenue is $-0.00B. That is a decrease of 100.00% year-over-year from $0.00B in FY2021.

KBPH revenueKBPH annual revenuewhat is KBPH revenueKBPH TTM revenue

Source: FMP · Kyto Technology and Life Science, Inc. SEC filings · GAAP · Kyto Technology and Life Science, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026